Follow The Filings

STRO Sutro Biopharma

Sutro Biopharma earnings company data as of 4:45 AM ET 11/1

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS -2.07 — —
Rev $13.6M — —

Insider trades

Open-market buys and sales by STRO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All STRO insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. David Pauling Chief Admin. Ofcr. & GC
    Buy
    $9,993 12,504 shares at $0.8000 +21% to stake
    Traded Oct 15, 2025 Filed Oct 16, 2025
    ↗
  2. Hans-Peter Gerber Chief Scientific Officer
    Buy
    $14K 17,000 shares at $0.8000 +31% to stake
    Traded Oct 15, 2025 Filed Oct 16, 2025
    ↗
  3. Jane Chung CEO
    Buy
    $10K 12,500 shares at $0.8000 +11% to stake
    Traded Oct 15, 2025 Filed Oct 16, 2025
    ↗
  4. Gregory K. Chow CFO
    Buy
    $16K 19,750 shares at $0.8100 New stake
    Traded Oct 15, 2025 Filed Oct 16, 2025
    ↗
  5. Connie Matsui Director
    Buy
    $40K 50,000 shares at $0.8000 New stake
    Traded Oct 15, 2025 Filed Oct 16, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 13 option exercises and 10 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 24 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
424B3 Filing Doc
8-K 1.02,2.02,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
424B5 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 15 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.